Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHLOVIS: Chlorhexidine vs Povidone Iodine for CRT Infection Prevention
NCT01841242Phase 4Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Apr 2013
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of chlorhexidine in surgical site infection (SSI) (2 arms), sponsored by CHU Saint-Etienne. Primary endpoint: Infection at 24 months. Started Apr 2013; status: completed.
02
Drugs
chlorhexidine
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT01841242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01841242.